Opioids in Chronic Non-Cancer Pain (CNCP): The Basics

Last updated on June 24, 2019

Earn up to 1.0 Mainpro-M1 credit* in about 30 minutes, held in your office at a time that is convenient for you.

Learning Objectives:

During the academic detailing session, participants will have the opportunity to discuss:

  1. The evidence (and the evidence gaps) for the benefits and harms of opioids in CNCP.
  2. The importance of an initial short-term, structured opioid trial.
  3. The characteristics of specific opioids and opioid formulations including:
    • how other opioids compare to morphine,
    • the evidence for using immediate-release vs. sustained-release formulations,
    • the propensity for drug interactions,
    • guidance for switching from one opioid to another, and
    • opioids best avoided in CNCP.
  4. The role of opioid stewardship to improve patient and public safety.
When: Available until June 2015
Where:  Your office at your convenience, or via live Web conference
How:  Email or Phone 604-660-2101

View some additional resources related to this topic (PDF, 249KB).

For more information about the PAD service, visit PAD Frequently Asked Questions.

* As an organization accredited to sponsor continuing medical education for physicians by the Committee on Accreditation of Canadian Medical Schools (CACMS), the UBC Division of Continuing Professional Development designates this educational program as meeting the accreditation criteria of the College of Family Physicians of Canada for 1.0 Mainpro-M1 credit. This program has been reviewed and approved by UBC Division of Continuing Professional Development. Each physician should claim only those credits he/she actually spent in the activity.